Need professional-grade analysis? Visit stockanalysis.com
$27.85M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Volitionrx Ltd (VNRX) Price Performance
Volitionrx Ltd (VNRX) trades on United States in USD. The company is classified in the Healthcare sector under the In Vitro & In Vivo Diagnostic Substances industry. The stock currently trades at $0.20, up 7.48% from the previous close.
Over the past year, VNRX has traded between a low of $0.19 and a high of $0.92. The stock has lost 60.6% over this period. It is currently 78.1% below its 52-week high.
Volitionrx Ltd has a market capitalization of $27.85M.
About Volitionrx Ltd
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.
Company Info
- Sector
- Healthcare
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $1.47M
- EBITDA
- $-21,653,004
- Profit Margin
- -2209.79%
- EPS (TTM)
- -0.23
- Book Value
- -0.32
Technical Indicators
- 52 Week High
- $0.94
- 52 Week Low
- $0.17
- 50 Day MA
- $0.25
- 200 Day MA
- $0.47
- Beta
- 1.36
Valuation
- Trailing P/E
- N/A
- Forward P/E
- -2.28
- Price/Sales
- 18.92
- Price/Book
- -0.65
- Enterprise Value
- $34.97M